# COVID-19: A Year After the New Normal in Bangladesh

This repository explores survey-based insights on COVID-19 trends in Bangladesh, one year after the initial global transition to the "new normal." The analysis focuses on patterns in infection recurrence, vaccine distribution, medication use, and age-wise impact.

<!-- ![image](https://github.com/SheikhMaleeha/COVID-after-New-Normal/blob/main/Visualization%20Snippets/Medications%20taken.png)
![image](https://github.com/SheikhMaleeha/COVID-after-New-Normal/blob/main/Visualization%20Snippets/covid%20recurrence.png) -->

<p align="center">
  <img src="Visualization Snippets/Medications taken.png" alt="Medication Usage" width="45%" />
  &nbsp; &nbsp;
  <img src="Visualization Snippets/covid recurrence.png" alt="Multiple COVID Cases" width="45%" />
</p>


## ðŸ§ª Overview

Despite global vaccination efforts, recurring COVID-19 cases continued to emerge. This project analyzes:

- Preventive medication usage across surveyed individuals
- COVID-19 recurrence by age group
- Vaccine distribution and correlation with COVID-negative cases
- Severity trends by age and symptom presence


## ðŸ§  Insights Summary

- Zinc and Vitamin tablets were more commonly used than prescription medications.
- Moderna was the leading vaccine among COVID-negative individuals.
- Ages 16â€“30 saw the highest recurrence of COVID cases.
- Some positive cases reported **no symptoms**, especially in older age groups.

![image](https://github.com/SheikhMaleeha/COVID-after-New-Normal/blob/main/Visualization%20Snippets/Medications%20COVID%20Protection.png)

To read more, please check out this [blog](https://medium.com/@maleehasheikh81/covid-19-a-year-after-the-new-normal-in-bangladesh-9a6dc99da7e6)
